Economic burden of metastatic melanoma in a commercially insured US population

被引：2
|
作者：
Ray, S.
Tunceli, O.
Ganguli, A.
Kamat, S.
Gu, T.
Singer, J.
Luo, Y.
Xu, Y.
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e19000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19000
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Economic Burden Of Moderate And Severe COPD Exacerbations In Commercially Insured And Medicare Part D Us Populations
    Stanford, R. H.
    Borse, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [22] Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population
    Mathews, Simon C.
    Izmailyan, Sergey
    Brito, Frances A.
    Yamal, Jose-Miguel
    Mikhail, Osama
    Revere, Frances L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (07) : 1480 - +
  • [23] INCIDENCE AND BURDEN OF RECURRENT VAGINITIS AMONG COMMERCIALLY INSURED WOMEN IN THE US
    Bonafede, M.
    Vilalta, A.
    Troeger, K. A.
    Kim, G.
    Onyekwere, U.
    VALUE IN HEALTH, 2020, 23 : S159 - S159
  • [24] Economic Burden of Systemic Lupus Erythematosus by Flare Severity in a Commercially Insured Population in the United States.
    Narayanan, Siva
    Durden, Emily
    Oglesby, Alan
    Juneau, Paul
    Wilson, Kathleen L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S405 - S405
  • [25] Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population
    Shah, Chintal H.
    Onukwugha, Eberechukwu
    Zafari, Zafar
    Villalonga-Olives, Ester
    Park, Jeong-eun
    Slejko, Julia F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 683 - 690
  • [26] ECONOMIC BURDEN OF COMORBIDITIES AMONG COPD PATIENTS EXPERIENCING ACUTE EXACERBATIONS: AN ANALYSIS OF A COMMERCIALLY INSURED POPULATION
    Shah, C.
    Onukwugha, E.
    Zafari, Z.
    Villalonga, Olives E.
    Park, J. E.
    Slejko, J. F.
    VALUE IN HEALTH, 2021, 24 : S214 - S214
  • [27] ECONOMIC BURDEN OF INTERSTITIAL LUNG DISEASE IN A COMMERCIALLY INSURED POPULATION WITH SJOGREN'S SYNDROME IN THE UNITED STATES
    Lee, T. Y.
    Slejko, J. F.
    Davies-Teye, B. B.
    Onukwugha, E.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [28] The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals
    Rice, J. Bradford
    Kirson, Noam Y.
    Shei, Amie
    Enloe, Caroline J.
    Cummings, Alice Kate G.
    Birnbaum, Howard G.
    Holly, Pamela
    Ben-Joseph, Rami
    POSTGRADUATE MEDICINE, 2014, 126 (04) : 53 - 58
  • [29] Economic Burden of Epilepsy among the Privately Insured in the US
    Jasmina I. Ivanova
    Howard G. Birnbaum
    Yohanne Kidolezi
    Ying Qiu
    David Mallett
    Sue Caleo
    PharmacoEconomics, 2010, 28 : 675 - 685
  • [30] Economic Burden of Epilepsy among the Privately Insured in the US
    Ivanova, Jasmina I.
    Birnbaum, Howard G.
    Kidolezi, Yohanne
    Qiu, Ying
    Mallett, David
    Caleo, Sue
    PHARMACOECONOMICS, 2010, 28 (08) : 675 - 685
12345